Zapaq Inc. merger with Athenagen Inc.
|
|
|
|
280 Utah Avenue. Suite 275 South San Francisco. CA 94080 USA |
| |
|
|
+1-650-869-7600 |
|
|
+1-650-869-7626 |
|
|
www.comentis.com |
|
|
|
|
|
|
characterized beta-secretase and its role in Alzheimer's disease and have developed a portfolio of drug candidates designed to inhibit the activity of this enzyme - develop compounds that inhibit aspartic proteases | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|